Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Cassiopea S.p.A.
  6. News
  7. Most relevant
    SKIN   IT0005108359

CASSIOPEA S.P.A.

(SKIN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CASSIOPEA S.P.A.
12/03Cosmo Pharmaceuticals Secures Over 93% Stake in Cassiopea at Tender Closing
MT
12/03CASSIOPEA S.P.A.(SWX : SKIN) dropped from Swiss Performance Index (Price Return)
CI
11/18Cosmo Pharmaceuticals to Start Additional Acceptance Period in Cassiopea Offer
MT
11/16Cosmo Pharmaceuticals Wins Shareholders Nod For Cassiopea Stake Deal
MT
11/16Cosmo Pharmaceuticals Raises Cassiopea Stake To Over 87%
MT
11/03Cassiopea's Partner Launches Winlevi Acne Treatment In US
MT
10/04COSMO PHARMACEUTICALS N : Initiates Public Exchange Offer For Cassiopea
MT
10/04CASSIOPEA S P A : Cosmo pharmaceuticals n.v. launchesápublic exchange offer to acquire cas..
EQ
10/04Cosmo Pharmaceuticals N.V. made an offer to acquire remaining 53.4% stake in Cassiopea ..
CI
10/04Cosmo Pharmaceuticals Intends to Acquire Cassiopea
CI
09/13CASSIOPEA S P A : Public Investor Presentation H.C. Wainwright Annual Global Conference
PU
09/10CASSIOPEA S P A : Female Androgenetic Alopecia Treatment Shows Improvement in Mid-Stage Tr..
MT
09/10Cassiopea SpA Announces Topline Results of Phase II Proof of Concept Trial of Clascoter..
CI
08/31CASSIOPEA S P A : Concludes License, Supply Deal for Acne Drug Winlevi
MT
07/29CASSIOPEA S P A : H1 Loss Swells to $7 Million
MT
07/29CASSIOPEA S P A : Announces Results for First Half of 2021
PU
07/29CASSIOPEA S P A : Half Year Report 2021
PU
07/29CASSIOPEA S P A : Half Year 2021 Financial Results Presentation
PU
07/29Cassiopea S.p.A. Provides Earnings Guidance for the Year 2021
CI
07/26CASSIOPEA S P A : Enters License, Supply Deals for Acne Treatment in North America
MT
07/26Sun Pharmaceutical Industries Ltd. and Cassiopea SpA Announces the Signing of License a..
CI
07/26CASSIOPEA S P A : SpA and Sun Pharma Announce Signing of Licenseáand Supply Agreements for..
EQ
07/22CASSIOPEA S P A : Test 1
PU
06/01CASSIOPEA S P A : Jefferies Virtual Healthcare Conference Presentation
PU
04/29CASSIOPEA S P A : Announces Results of AGM 2021
PU
04/29CASSIOPEA S P A : announces results of AGM 2021
EQ
04/29Cassiopea S.P.A. Announces Board Changes
CI
04/21CASSIOPEA S P A : Lists of Candidates for the Board of Directors at the AGM 2021
PU
04/21CASSIOPEA S P A : Lists of candidates for the board of directors at the AGM 2021
EQ
04/07CASSIOPEA S P A : 2021 General Assembly / Assemblea degli azionisti
PU
03/25CASSIOPEA S P A : FY20 Loss Grows to $14.5 Million
MT
03/25CASSIOPEA S P A : Reports Year End 2020 Results
EQ
03/25CASSIOPEA S P A : Reports Year End 2020 Results
PU
03/25CASSIOPEA S P A : Annual Report 2020
PU
03/25CASSIOPEA S P A : 2020 Financial Results Presentation
PU
03/25Cassiopea S.P.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
03/08CASSIOPEA S P A : H.C. Wainwright Global Life Sciences Conference
PU
03/01CASSIOPEA S P A : Credit Suisse London Global Healthcare Conference Presentation
PU
2020CASSIOPEA S P A : to Appoint New CFO in January 2021
MT
2020Cassiopea Announces Management Change
TE
2020CASSIOPEA S P A : Credit Suisse & Jefferies Presentation
PU
2020CASSIOPEA S P A : Credit Suisse & Jefferies Presentation
PU
2020Albany Molecular Research Inc. Names Exclusive API Supplier for Recently Approved Acne ..
CI
2020CASSIOPEA S P A : Announces completion of enrollment in a phase ii trial of clascoterone s..
AQ
2020Cassiopea Announces Completion of Enrollment in a Phase II Trial of Clascoterone Soluti..
TE
2020Cassiopea Announces Completion of Enrollment in A Phase II Trial of Clascoterone Soluti..
CI
2020Cassiopea to present at the H.C. Wainwright Global Investment Conference
TE
2020COSMO PHARMACEUTICALS N : announces FDA Approval for Cassiopea's Winlevi, First-in-Class T..
AQ
2020CASSIOPEA S P A : Receives fda approval for winlevi, first-in-class topical acne treatment..
AQ
2020GLOBAL MARKETS LIVE: Rising tensions
2020Cassiopea gets U.S. FDA approval for acne treatment Winlevi
RE
2020CASSIOPEA S P A : Receives FDA Approval for Winlevi « (clascoterone cream 1%), First-in-Cl..
PU
2020Cassiopea SpA Spa Receives FDA Approval for Winlevi
CI
2020Cassiopea Receives FDA Approval for Winlevi« (clascoterone cream 1%), First-in-Class To..
TE
2020Cassiopea Announces Results for First Half of 2020
TE
2020Cassiopea S.P.A. Announces Earnings Results for the Six Months Ended June 30, 2020
CI
2020Cassiopea Announces JAAD Publication of Positive Results from Long-Term Safety Study of..
CI
2020Cassiopea Announces JAAD Publication of Positive Results from A Long-Term Safety Study ..
TE
2020Cassiopea announces that SIX has informed it that trading of its shares is suspended pe..
TE
2020Cassiopea announces completion of the rights offering – gross proceeds of EUR 23...
TE
2020Cassiopea announces results of extraordinary shareholders meeting
TE
2020Cassiopea announces EUR 23.25 million capital increase
TE
2020Cassiopea Announces Results for First Quarter 2020
TE
2020Cassiopea S.P.A. Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
2020Cassiopea announces results of ordinary shareholders meeting
TE
2020Cassiopea announces 2019 Results in line with expectations
TE
2020Lists of candidates for the board of directors at the AGM 2020
TE
2020Cassiopea announces 2019 Results in line with expectations
TE
2020Cassiopea S.P.A. Reports Earnings Results for the Full Year Ended December 31, 2019
CI
2020Chris Tanner to Retire from Cassiopea at Latest at Year End 2020
CI
2020CASSIOPEA S P A : Upside-down jellyfish can launch venomous balls of mucus
AQ
2019Cassiopea S.P.A. Announces First Patient to Be Enrolled in Phase II Trial for the Treat..
CI
2019Cassiopea Announces First Patient to be Enrolled in Phase II Trial for the Treatment of..
TE
2019Cassiopea Announces FDA Acceptance of its New Drug Application for Clascoterone Cream 1..
CI
2019Cassiopea Announces FDA Acceptance of its New Drug Application for Clascoterone Cream 1..
TE
1  2Next
Upcoming event on CASSIOPEA S.P.A.
02/24/22